The treatment of the congenital nasolacrimal duct obstruction

Shu Han; Hui Zhu; Xiao-Jun Zhang

doi:10.3980/j.issn.1672-5123.2020.8.13

Guoji Yanke Zazhi (Aug 2020)

The treatment of the congenital nasolacrimal duct obstruction

Shu Han,
Hui Zhu,
Xiao-Jun Zhang

Affiliations

Shu Han: Department of Ophthalmology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China
Hui Zhu: Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
Xiao-Jun Zhang: Department of Ophthalmology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China

DOI: https://doi.org/10.3980/j.issn.1672-5123.2020.8.13
Journal volume & issue: Vol. 20, no. 8
pp. 1359 – 1362

Abstract

Read online

Congenital nasolacrimal duct obstruction(CNLDO)has an incidence rate of 5.7% and there are many clinical treatments for the disease. But these treatments have been taken very randomly. Therefore, it is still a controversial topic on how to choose the best treatment. This paper will discuss the treatments of CNLDO so as to know the characteristics of each treatment for better clinical services.

Published in Guoji Yanke Zazhi

ISSN: 1672-5123 (Print)
Publisher: Press of International Journal of Ophthalmology (IJO PRESS)
Country of publisher: China
LCC subjects: Medicine: Ophthalmology
Website: http://ies.ijo.cn/

About the journal

Abstract

Keywords